TrimRx vs Ro vs PlexusDx (2026)

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you're cross-shopping TrimRx and Ro for cash-pay GLP-1 weight loss, the headline numbers are misleading. TrimRx markets compounded semaglutide from roughly $199/mo on promotional plans and compounded tirzepatide from roughly $349/mo, all-inclusive. Ro markets a $149/mo Body membership that covers the consultation and concierge but charges medication on top — meaning a Wegovy pen, Wegovy pill, or Zepbound vial is billed separately. The two pricing structures look comparable on a landing page; the actual annual outlay is not. This article walks the real cost math, the compounded-vs-FDA-approved medication-source split, the safety considerations on each side, and where PlexusDx Semaglutide Injection, Tirzepatide Injection, and Microdose GLP-1 Protocol sit relative to both — because the choice between TrimRx, Ro, and PlexusDx isn't really about which company is “better.” It's about medication source, oversight model, total annualized cost, and whether your genetics inform dose selection before week one.

TrimRx vs Ro vs PlexusDx — the quick decision frame

Three pricing models cover the cash-pay GLP-1 market in 2026. TrimRx is an all-inclusive compounded-medication platform: roughly $199–$349/month covers the clinician visit, the compounded semaglutide or tirzepatide vials, supplies, and shipping in one bill, with no separate membership. Ro is a membership-plus-medication model: $149/month buys the clinical visit, the insurance concierge, coaching, and prescription routing; the medication is then dispensed at retail or insurance-adjusted pricing — typically Wegovy or Zepbound at the FDA-approved branded list price (Wegovy pens from ~$199/mo on promotional dosing up to ~$349/mo, Zepbound vials from $249-$369/mo, and the new Wegovy pill from $149/mo on the lowest dose), all on top of the $149 membership. PlexusDx Weight Management Protocols use compounded semaglutide and tirzepatide from licensed U.S. compounding pharmacies — Semaglutide Injection at $149/mo, Tirzepatide Injection at $249/mo, Microdose GLP-1 Protocol at $129/mo flat, and GLP-Squared dual-compound at $249/mo — paired with the optional Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month) so dosing decisions are anchored to the patient's GIPR, GLP1R, FTO, MC4R, and TCF7L2 variants rather than starting from population averages. All three pricing models are cash-pay; PlexusDx adds no membership fee.

The real annual cost: TrimRx vs Ro vs PlexusDx

For a cash-pay patient with no insurance coverage for weight-loss drugs, TrimRx's promotional all-inclusive compounded-semaglutide pricing produces a total of roughly $2,388/year ($199 × 12), with compounded tirzepatide running closer to $4,188/year ($349 × 12) at promotional rates. Ro's $149/month membership stacks on top of medication: cash-pay totals run $294–$494/mo for semaglutide options and $444–$594/mo for Zepbound — roughly $3,528–$5,928/year before any prior-authorization wins. PlexusDx Weight Management Protocols range from $1,548/year on the Microdose GLP-1 Protocol ($129/mo flat) to $2,148–$2,748/year on Semaglutide Injection ($149/mo), $2,748–$3,708/year on Tirzepatide Injection ($249/mo), or $2,148–$3,900/year on GLP-Squared ($249/mo). Add $99 for the Precision Peptide Genetic Test as an add-on after month one and the genetic-baseline-included totals stay below TrimRx's promotional tirzepatide tier and well below Ro's cash-pay tirzepatide tier. If your insurance reliably covers Wegovy or Zepbound at a low copay, Ro's branded-pharmacy concierge route can still win on cost. If your insurance doesn't cover GLP-1s for weight loss — the situation for the majority of commercial plans as of 2026 — PlexusDx's protocol pricing is meaningfully below TrimRx at the entry tier and competitive with TrimRx at the higher tiers, with a genetic-baseline option neither competitor offers.

Compounded vs FDA-approved branded — what each platform actually dispenses

This is the substantive medication difference, and it matters before you sign up for any of the three. TrimRx's core all-inclusive plans dispense compounded semaglutide and compounded tirzepatide — formulations prepared by a licensed compounding pharmacy under U.S. compounding regulations. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products; they are pharmacy-prepared versions of the same active ingredients found in Wegovy, Ozempic, Mounjaro, and Zepbound, and they have not gone through their own FDA clinical trial and approval process. Ro's primary path dispenses FDA-approved branded GLP-1 medications — Wegovy (semaglutide pen and the new daily Wegovy pill), Zepbound (tirzepatide KwikPen and self-pay vials), with Ozempic available off-label — the same products that ran the SUSTAIN, STEP, and SURMOUNT trials. PlexusDx Weight Management Protocols use compounded semaglutide and tirzepatide like TrimRx, but offer four delivery formats — weekly injection, daily oral tablet, microdose troche/capsule/lozenge/sublingual, and dual-compound stacks — at protocol-specific dose ranges, paired with a genetic baseline. The compounded vs branded choice is not about effectiveness of the active ingredient; it's about FDA approval status of the finished product, supply consistency under post-shortage regulations, and which regulatory framework governs your medication.

Pill vs injection: oral options on each platform

Ro added the FDA-approved Wegovy pill (daily oral semaglutide) to its line-up — the first oral GLP-1 cleared specifically for weight loss — starting at $149/mo for the lowest dose plus the $149 membership. TrimRx advertises an oral semaglutide path on its site, but the regulatory status of that specific compounded oral product should be verified directly with TrimRx at checkout. PlexusDx offers two distinct oral compounded options: Semaglutide Oral at $249/mo for daily compounded semaglutide tablets across six dose levels, and Tirzepatide Oral at $279/mo for daily compounded tirzepatide tablets across seven dose levels. Pill vs injection mostly comes down to absorption pharmacokinetics, daily-vs-weekly preference, and whether nausea profile differs for the patient — not a cost-or-effectiveness ceiling that only one platform breaks.

Safety, side effects, and clinical oversight

All three programs prescribe medications in the GLP-1 receptor agonist class (and tirzepatide, a GIP/GLP-1 dual agonist). The FDA-labeled side-effect profile is well-characterized: nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common; pancreatitis, gallbladder disease, and acute kidney injury are less common but documented; the boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies. The clinical-oversight question differs by platform. Ro routes prescriptions through licensed providers and partner pharmacies, with the FDA-approved label and post-market surveillance applying directly. TrimRx routes through a licensed clinician and a compounding pharmacy, with provider messaging and check-ins after intake. PlexusDx uses licensed U.S. compounding pharmacies and a clinical team that reviews the patient's Precision Peptide Genetic Test before titration when the test is included — a stratification step neither TrimRx nor Ro performs. PlexusDx is available in all 50 states; five states require a scheduled live consultation rather than async intake.

Why genetics matter before you choose

GLP-1 response varies meaningfully across patients. Variants in GIPR (the GIP receptor that tirzepatide binds), GLP1R (the GLP-1 receptor itself), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide. The Precision Peptide Genetic Test maps 48 genes and 57 variants across 14 health pathways — including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response — so the prescribing clinician knows whether a faster-than-typical titration, a slower one, or a tirzepatide-first approach is more likely to fit your biology before week one. Neither TrimRx nor Ro performs this step — both start from a population-average titration schedule and adjust based on subjective tolerability over the first 8–12 weeks. PlexusDx anchors that same conversation to a measurable genetic baseline, available standalone for $298 or as a $99 add-on after your first month on any protocol. For patients who suspect they're a slow responder, who plateaued on semaglutide, or who want to know whether tirzepatide's GIP arm is likely to add value for their specific GIPR genotype, that baseline is the difference between informed escalation and trial-and-error.

Cancellation, refills, and what to verify before checkout

TrimRx advertises month-to-month billing with cancellation via chat or phone; their terms note that previously processed charges are non-refundable, so verify the exact refund policy in your checkout flow before submitting payment. Ro is also month-to-month — you cancel through the account dashboard or by emailing support at least 48 hours before the next billing date, and the current month's membership fee is non-refundable. PlexusDx is cash-pay with no membership and no long-term commitment; you pay per month on the protocol you're prescribed and stop when you stop. If you escalate dose mid-protocol on PlexusDx, the protocol's published price ladder applies (e.g., Tirzepatide Injection ranges $249/mo across six dose levels) rather than a flat-rate-becomes-surcharge model. Across all three, the items worth verifying before you enter a card are: total month-1 vs month-12 cost at your expected dose, whether labs are required and whether the platform covers them, the medication's regulatory status (compounded vs branded), and the cancellation/refund language for the specific plan you select.

Which one fits — a four-question frame

Question 1: Does your insurance reliably cover Wegovy or Zepbound at a low copay? If yes, Ro's concierge is the most likely path to the lowest out-of-pocket cost. Question 2: Are you cash-pay with no GLP-1 coverage and price is the dominant factor? Compare TrimRx's $2,388–$4,188/year promotional all-inclusive against PlexusDx Microdose GLP-1 Protocol at $1,548/year or Semaglutide Injection at $2,148–$2,748/year. Question 3: Do you want the FDA-approved branded product specifically — Wegovy pen, Wegovy pill, or Zepbound? Ro is the only one of the three that dispenses those directly. Question 4: Do you want a genetic baseline informing dose and titration before the first injection, and a dual-compound option (semaglutide + tirzepatide stacked) if a single-agent plateau hits? PlexusDx is the only option in this comparison that includes the Precision Peptide Genetic Test and the GLP-Squared dual-compound protocol as part of the protocol pathway.

Frequently asked questions

Is TrimRx cheaper than Ro?

For cash-pay patients with no GLP-1 insurance coverage, generally yes — TrimRx's promotional compounded semaglutide starts around $199/mo all-inclusive vs Ro's $294/mo minimum (the $149 membership plus the lowest-priced medication). With strong insurance coverage of Wegovy or Zepbound, Ro can come out lower. PlexusDx Microdose GLP-1 Protocol at $129/mo flat undercuts both for cash-pay patients who fit that protocol.

Does Ro's $149/month include medication?

No. The $149/mo Ro Body membership covers provider consultations, coaching, the insurance concierge, and app access. Medication is billed separately — from $149/mo for the lowest-dose Wegovy pill up to $449/mo or higher for Zepbound vials, on top of the membership.

Is compounded semaglutide FDA-approved?

No. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are prepared by licensed compounding pharmacies using pharmaceutical-grade ingredients but have not gone through the FDA's clinical trial and approval process. This applies to TrimRx's compounded line and to PlexusDx Weight Management Protocols; only branded products like Wegovy and Zepbound (Ro's primary path) are FDA-approved finished products.

Does Ro offer a pill instead of injections?

Yes — Ro now offers the Wegovy pill, the first FDA-approved oral GLP-1 for weight loss, starting at $149/mo for the lowest dose plus the $149/mo membership. PlexusDx offers compounded oral options too: Semaglutide Oral at $249/mo and Tirzepatide Oral at $279/mo.

Does TrimRx offer Wegovy or Zepbound?

Not through their standard compounded program. TrimRx's core offering is compounded semaglutide and compounded tirzepatide. They do list branded medications on their site at significantly higher price points, but their value proposition centers on the compounded path. For FDA-approved Wegovy or Zepbound dispensed directly, Ro is the clearer current option.

How fast can I start medication?

TrimRx advertises roughly one week from signup to medication delivery. Ro is under a week for cash-pay options and two-plus weeks if going through the insurance track because prior authorization adds time. PlexusDx Weight Management Protocols ship after async intake review (or a scheduled live consult in the five states that require it).

Which platform tells me whether GLP-1 will work for my genetics before I start?

Only PlexusDx offers a paired genetic baseline. The Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month) reports on GIPR rs1800437 and other variants associated with differential GLP-1 response, so the prescribing clinician can stratify titration and choice between semaglutide, tirzepatide, or the GLP-Squared dual-compound before week one. TrimRx and Ro both start from a population-average titration schedule.

TrimRx vs Ro vs PlexusDx (2026): Real Cost, Compounded vs Branded, and Genetics | PlexusDx